Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Myelodysplastic Syndromes 48Leukemia 46Anemia, Refractory, with Excess of Blasts 43Leukemia, Myeloid, Acute 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Myelomonocytic, Chronic 29Leukemia, Myeloid, Chronic-Phase 26Lymphoma 25Myeloproliferative Disorders 22Multiple Myeloma 22Lymphoma, Non-Hodgkin 21Leukemia, Myeloid, Accelerated Phase 21Congenital Abnormalities 21Leukemia, Lymphocytic, Chronic, B-Cell 20Blast Crisis 20Anemia, Refractory 20Burkitt Lymphoma 17Myelodysplastic-Myeloproliferative Diseases 16Hodgkin Disease 16Primary Myelofibrosis 15Lymphoma, Follicular 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Aplastic 14Neoplasms, Plasma Cell 13Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, B-Cell, Marginal Zone 13Recurrence 11

Interventions

fludarabine 4fludarabine phosphate 3Thiotepa 2Melphalan 2Clofarabine 2Busulfan 2AP 1903 reagent 2Tacrolimus 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Cyclosporins 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemoglobinopathies × Busulfan × Classical hematology × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡